Roivant Sciences Ltd.

By person

15 insiders · 120 transactions

916×

Matthew Gline holds 916 times base salary in stock. $664.73M of shares against $725.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Matthew Gline last reported holding, valued at $39.90, the price Common Shares was last bought or sold at on the open market here, on 8 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

MANCHESTER KEITH S

Director

—

$154.47M (20)

−$154.47M

15,437,569

2.14%

$615.96M

−60.6%

Gold Daniel Allen

Director

—

$147.38M (19)

−$147.38M

22,649,927

3.14%

$903.73M

−67.4%

QVT Financial LP entity

Director by Deputization

—

$147.38M (19)

−$147.38M

13,689,166

1.90%

$546.20M

−76.0%

Venker Eric

President & Immunovant CEO

—

$115.29M (26) scheduled

−$115.29M

1,599,154

0.2214%

$63.81M

+150.1%

Sukhatme Mayukh

President & CIO

—

$109.13M (13) scheduled

−$109.13M

18,630,739

2.58%

$743.37M

−17.2%

Ramaswamy Vivek

10% owner

—

$105.88M (6) scheduled

−$105.88M

47,011,612

6.51%

$1.88B

−12.0%

Torti Frank

President and Vant Chair

—

$82.04M (3) scheduled

−$82.04M

13,536,202

1.87%

$540.09M

—

Gline Matthew

CEO

$49.96K (1)

$46.17M (4) scheduled

−$46.12M

16,659,945

2.31%

$664.73M

−9.0%

Pulik Richard

CFO

—

$9.12M (2) scheduled

−$9.12M

271,810

0.0376%

$10.85M

−5.9%

Fitzgerald Meghan

Director

—

$3.07M (3) scheduled

−$3.07M

41,220

0.0057%

$1.64M

+40.3%

Epperly Melissa B,

Director

—

$1.81M (3)

−$1.81M

14,838

0.0021%

$592.04K

−59.3%

Humes Jennifer

Chief Accounting Officer

—

$384.07K (1)

−$384.07K

109,782

0.0152%

$4.38M

—

Kumar Rakhi

Chief Accounting Officer

—

162,306

0.0225%

$6.48M

−23.6%

Oren Ilan

Director

—

118,626

0.0164%

$4.73M

+24.1%

MOMTAZEE JAMES C

Director

—

106,905

0.0148%

$4.27M

+15.7%

By person

Individual transactions

What was left out